Back to results
US 10,196,614 B2Granted
Compositions and methods for antigen targeting to CD180
AssigneeUniversity of Washington through its Center for Commercialization
InventorsEdward Clark, Jay Wesley Chaplin
Life of this patent
Estimating the term…
Abstract
The present limiting provides compositions of CD 180 targeting molecules coupled to heterologous antigens, and their use in treating and/or limiting disease.
Claims23
A composition, comprising:
- (a) an antibody that selectively binds CD180 or an antigen binding fragment thereof;
- and
- (b) a heterologous polypeptide antigen attached to the antibody or the antigen binding fragment thereof, wherein the heterologous polypeptide antigen is selected from the group consisting of a West Nile virus antigen, a hepatitis virus antigen, and a dengue virus antigen.
Dependencies are inferred from the claim text.